SCHEMBL6660160

SCHEMBL6660160

CC(OCCOCCN)OCCOCCN

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15256805 0.91 HSD17B10 (0.37) LMNA
SCHEMBL20840050 0.88
SCHEMBL4369249 0.88
SCHEMBL10703153 0.87 ALDH1A1 (0.30)
SCHEMBL23205536 0.84
SCHEMBL22965433 0.84
SCHEMBL26193306 0.84
SCHEMBL12448104 0.84
SCHEMBL22853800 0.84
SCHEMBL1535731 0.83 LMNA (0.42) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023149435-A1 RESIN COMPOSITION, MOLDED OBJECT, AND FILM 株式会社カネカ 2023-08-10 WO disclosed
EP-3741773-A1 MEDITOPES AND MEDITOPE-BINDING ANTIBODIES AND USES THEREOF City of Hope (US) 2020-11-25 EP disclosed
US-10752748-B2 Methods for recycling reinforced composites ADESSO ADVANCED MATERIALS WUHU CO., LTD. (CN) 2020-08-25 US disclosed
US-20200239659-A9 METHODS FOR RECYCLING REINFORCED COMPOSITES CHANGSHA ADESSO ADVANCED MATERIALS CORPORATION LIMITED (CN) 2020-07-30 US disclosed
EP-2766382-B1 MEDITOPES AND MEDITOPE-BINDING ANTIBODIES AND USES THEREOF HOPE CITY (US) 2020-05-06 EP disclosed
US-20180241076-A1 NEGATIVE ELECTRODE FOR LITHIUM ION SECONDARY BATTERY, LITHIUM ION SECONDARY BATTERY COMPRISING SAME, AND METHOD FOR PRODUCING NEGATIVE ELECTRODE FOR LITHIUM ION SECONDARY BATTERY MITSUI CHEMICALS, INC. (JP) 2018-08-23 US disclosed
EP-2688955-B1 REINFORCED COMPOSITE AND METHOD FOR RECYCLING THE SAME ADESSO ADVANCED MAT WUXI CO LTD (CN) 2018-07-11 EP disclosed
EP-3333942-A1 NEGATIVE ELECTRODE FOR LITHIUM ION SECONDARY BATTERY, LITHIUM ION SECONDARY BATTERY COMPRISING SAME, AND METHOD FOR PRODUCING NEGATIVE ELECTRODE FOR LITHIUM ION SECONDARY BATTERY Mitsui Chemicals, Inc. (JP) 2018-06-13 EP disclosed
US-20170145180-A1 METHODS FOR RECYCLING REINFORCED COMPOSITES ADESSO ADVANCED MAT WUHU CO LTD (CN) 2017-05-25 US disclosed
US-20170145180-A1 METHODS FOR RECYCLING REINFORCED COMPOSITES ADESSO ADVANCED MAT WUHU CO LTD (CN) 2017-05-25 US disclosed
US-20140221510-A1 REINFORCED COMPOSITE AND METHOD FOR RECYCLING THE SAME ADESSO ADVANCED MATERIALS WUXI CO., LTD. (CN) 2014-08-07 US disclosed
US-20140221510-A1 REINFORCED COMPOSITE AND METHOD FOR RECYCLING THE SAME ADESSO ADVANCED MATERIALS WUXI CO., LTD. (CN) 2014-08-07 US disclosed
US-20140113348-A1 MEDITOPES AND MEDITOPE-BINDING ANTIBODIES AND USES THEREOF CITY OF HOPE (US) 2014-04-24 US disclosed
US-20130245204-A1 NOVEL AGENTS FOR REWORKABLE EPOXY RESINS CONNORA TECHNOLOGIES, INC. (US) 2013-09-19 US disclosed
WO-2013055404-A1 MEDITOPES AND MEDITOPE-BINDING ANTIBODIES AND USES THEREOF CITY OF HOPE (US) 2013-04-18 WO disclosed
WO-2013007128-A1 REINFORCED COMPOSITE AND METHOD FOR RECYCLING THE SAME ADESSO ADVANCED MATERIALS WUXI CO., LTD. (CN) 2013-01-17 WO disclosed
US-20120301400-A1 MEDITOPES AND MEDITOPE-BINDING ANTIBODIES AND USES THEREOF CITY OF HOPE 2012-11-29 US disclosed
US-20120301718-A1 METAL-RESIN COMPOSITE MITSUI CHEMICALS, INC. (JP) 2012-11-29 US disclosed
WO-2012071896-A1 NOVEL AGENTS FOR REWORKABLE EPOXY RESINS WUXI ADESSONANOTECH CO., LIMITED (CN) 2012-06-07 WO disclosed
JP-2004319448-A VACUUM ENVELOPE FOR IMAGE DISPLAY DEVICE, SEALANT FOR IMAGE DISPLAY DEVICE, IMAGE DISPLAY DEVICE, AND SEALING METHOD OF VACUUM ENVELOPE FOR IMAGE DISPLAY DEVICE MITSUI CHEMICALS INC 2004-11-11 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140113348-A1 MEDITOPES AND MEDITOPE-BINDING ANTIBODIES AND USES THEREOF FCGR3B, FCGR2A, FCGR1A LMNA 3689/4885
US-20120301400-A1 MEDITOPES AND MEDITOPE-BINDING ANTIBODIES AND USES THEREOF FCGR3B, FCGR2A, FCGR1A LMNA 3689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.